• 1
    Vardy J, Wefle JS, Ahles T, Tannock IF, Schagen SE. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 2008;19:623629.
  • 2
    Ahles TA, Root JC, Ryan EL. Cancer- and cancer treatment—Associated cognitive change: an update on the state of the science. J Clin Oncol 2012;Oct 20 (30):36753686.
  • 3
    Schagen SB, Vardy J. Cognitive dysfunction in people with cancer. Lancet Oncol 2007;8(10):852853.
  • 4
    Shilling V, Jenkins V. Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. Euro J of Oncol Nurs 2007;11(1):615.
  • 5
    Vardy J, Rourke S, Tannock IF. Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol 2007;25(17):24552463.
  • 6
    Schmeichel, B. J. Attention control, memory updating, and emotion regulation temporarily reduce the capacity for executive control. J Exp Psych: Gen 2007;136:241255.
  • 7
    Schagen SB, Das E, van Dam FSAM. The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients. Psycho-Oncology 2009;18(6):674678.
  • 8
    Dietrich J, Monje M, Wefel J, et al. Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist 2008; 13:12851295.
  • 9
    Wefel JS, Kayl AE, Meyers CA. Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target. Br J Cancer 2004;90:16911696.
  • 10
    Wefel JS, Schagen SB. Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep 2012;12:26775.
  • 11
    Anderson-Hanley C, Sherman ML, Riggs R, Agocha VB, Compas BE. Neuropsychological effects of treatments for adults with cancer: a metaanalysis and review of the literature. J Int Neuropsychol Soc 2003;9:96782.
  • 12
    Jansen CE, Miaskowski C, Dodd M, Dowling G, Kramer J. A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer 2005;104:22222233.
  • 13
    Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips K. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain and Cog 2005;59:6070.
  • 14
    Stewart A, Bielajew C, Collins B, Parkinson M, Tomiak E. A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol 2006;20:7689.
  • 15
    Deprez S, Amant F, Smeets A, et al. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol 2012;20:27481.
  • 16
    de Ruiter MB, Reneman L, Boogerd W, et al. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Hum Brain Map 2012;33(12):29712983.
  • 17
    Gong X, Schwartz PH, Linskey ME, et al. Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy. Neurology 2011;76:11261134.
  • 18
    Koppelmans V, de Ruiter MB, van der Lijn F et al. Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Res Treat 2011; Epub Dec 29.
  • 19
    McDonald BC, Conroy SK, Ahles TA, et al. Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res Treat 2010;123(3):81928.
  • 20
    Monje M, Dietrich J. Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis. Behav Brain Res 2011;227:376379.
  • 21
    Seigers R, Fardell JE. Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research. Neuroscience and Biobehavioral Rev 2011;35:729741.
  • 22
    Rodin G, Ahles TA. Accumulating evidence for the effect of chemotherapy on cognition. J Clin Oncol 2012;30(20):35683569.
  • 23
    Reid-Arndt SA. The potential for neuropsychology to inform functional outcomes research with breast cancer survivors. NeuroRehabilitation 2006;21(1):5164.
  • 24
    Boykoff N, Moieni M, Subramanian SK. Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response. J Cancer Surv 2009;3:223232.
  • 25
    Joly F, Rigal O, Noal S, Giffard B. Cognitive dysfunction and cancer: which consequences in terms of disease management? Psycho-Oncology 2011;20(12):12511258.
  • 26
    Hagger MS, Wood C, Stiff C, Chatzisarantis, NLD. Ego-depletion and the strength model of self-control: a meta-analysis. Psychol Bull 2010;136:496525.
  • 27
    Baumeister RF, Bratslavsky E, Muraven M, Tice DM. Ego depletion: is the active self a limited resource? J Pers Soc Psychol 1998;74:12521265.
  • 28
    Baumeister RF, Heatherton TF. Self-regulation failure: an overview. Psychol Inq 1996;7:115.
  • 29
    Hall PA, Fong GT. Temporal self-regulation theory: a model for individual health behavior. Health Psychol Rev 2007;1:652.
  • 30
    Inzlicht M, Schmeichel BJ. What is ego depletion? Toward a mechanistic revision of the resource model of self-control. Perspec on Psychol Science 2012;7:450463.
  • 31
    Vohs KD, Glass BD, Maddox WT, Markman AB. Ego depletion is not just fatigue: evidence from a total sleep deprivation experiment. Soc Psychol Pers Science 2011;2:166173.
  • 32
    Blair C, Ursache A. A bidirectional theory of executive functions and self-regulation. In R. Baumeister & K. Vohs (Eds.), Handbook of Self-Regulation (2nd ed., pp. 300320). New York: Guilford, 2011.
  • 33
    Kaplan S, Berman MG. Directed attention as a common resource for executive functioning and self-regulation. Perspectives on Psychol Science 2010;5:4357.
  • 34
    Schmeichel BJ, Vohs KD, Baumeister RF. Intellectual performance and ego depletion: role of the self in logical reasoning and other information processing. J Pers Soc Psychol 2003;85:3346.
  • 35
    Beauregard M, Lévesque J, Bourgouin P. Neural correlates of conscious self-regulation of emotion. J Neuroscience, 2001;21:69937000.
  • 36
    Blair C, Razza RP. Relating effortful control, executive function, and false-belief understanding to emerging math and literacy ability in kindergarten. Child Dev 2007;78:647663.
  • 37
    Gyurak A, Goodkind MS, Madan A, Kramer JH, Miller BL, Levenson RW. Do tests of executive functioning predict ability to down regulate emotions spontaneously and when instructed to suppress? Cog Affect & Beh Neuroscience 2009;9:144152.
  • 38
    Ochsner KN, Ray RD, Cooper JC, Robertson ER, Chopra S, Gabrieli JDE, Gross JJ. For better or for worse: neural systems supporting the cognitive down- and up-regulation of negative emotion. Neuroimage 2004;23:483499.
  • 39
    Solberg Nes L, Roach AR, Segerstrom SC. Executive functions, self-regulation, and chronic pain: a review. Ann Beh Med 2009;37:17383.
  • 40
    Muraven MR, Baumeister RF. Self-regulation and depletion of limited resources: does self-control resemble a muscle? Psychol Bull 2001:126:247259.
  • 41
    Cimprich B. Pretreatment symptom distress in women newly diagnosed with breast cancer. Cancer Nurs 1999;22:185194.
  • 42
    Reid-Arndt SA, Cox CR. Does rurality affect quality of life following treatment for breast cancer? J Rural Health 2010;26:402405.
  • 43
    Arndt J, Cook A, Goldenberg JL, Cox CR. Cancer and the threat of death: the cognitive dynamics of death thought suppression and its impact on behavioral health intentions. J Pers Soc Psychol 2007;92:1229.
  • 44
    Moser RP, Arndt J, Han P, Waters E, Amsellem M, Hesse B. Perceptions of cancer as a death sentence: prevalence and consequences. J Health Psychol (nd). in press.
  • 45
    Cox CR, Reid-Arndt SA, Arndt, J. Considering the unspoken: the role of death cognition in quality of life among women with and without breast cancer. J Psychosocial Oncol 2012;30:128139.
  • 46
    Little M, Sayers EJ. The skull beneath the skin: cancer survival and awareness of death. Psycho-Oncology 2004;13:190198.
  • 47
    Gailliot MT, Schmeichel B J, Baumeister RF. Self-regulatory processes defend against the threat of death: effects of self-control depletion and trait self-control on thoughts and fears of dying. J Pers Soc Psychol 2006;91:4962.
  • 48
    Schmeichel BJ, Demaree HA, Robinson JL, Pu J. Ego depletion by response exaggeration. J Exper Soc Psychol 2006;42:95102.
  • 49
    Cimprich B. Development of an intervention to restore attention in persons with cancer. Cancer Nurs 1993;16:8392.
  • 50
    Cimprich B, Ronis D. An environmental intervention to restore attention in women newly diagnosed with breast cancer. Cancer Nurs 2003;26:284292.
  • 51
    Tangney JP, Baumeister RF, Boone AL. High self-control predicts good adjustment, less pathology, better grades, and interpersonal success. J Pers 2004;72:271322.
  • 52
    Bauer IM, Baumeister RF. Self-regulatory strength. In K Vohs, R Baumeister (Eds.), Handbook of Self-Regulation: Research, Theory, and Applications (2nd Edn, pp. 64–82). New York: Guilford, 2011.
  • 53
    Webb TL, Sheeran P. Can implementation intentions help to overcome ego-depletion? J Exper Soc Psychol 2003;39:279286. DOI:10.1016/S0022-1031(02)00527-9
  • 54
    Rief W, Hoffmann G, Nestoriuc Y. The power of expectation: understanding the placebo and nocebo phenomenon. Soc Pers Psychol Compass 2008;2:13451361.
  • 55
    Hahn RA. Expectancies of sickness: concept and evidence of the nocebo phenomenon. In I. Kirsch (Ed.), How Expectancies Shape Experience (pp. 333356). Washington, DC: American Psychological Association, 1999.
  • 56
    Job V, Dweck CS, Walton GM. Ego depletion-Is it all in your head? Implicit theories about willpower affect self-regulation. Psychol Sci 2010;21:16861693.
  • 57
    Inzlicht M, McKay L, Aronson J. Stigma as ego depletion: how being the target of prejudice affects self-control. Psychol Sci 2006;17:262269.
    Direct Link:
  • 58
    Steele CM. A threat in the air: how stereotypes shape intellectual identity and performance. Am Psychol 1997;52:613629.
  • 59
    Steele C, Aronson J. Stereotype threat and the intellectual test performance of African Americans. J Pers Soc Psychol 1995;69(5):797811.
  • 60
    Cadinu M, Maass A, Rosabianca A, Kiesner J. Why do women underperform under stereotype threat? Evidence for the role of negative thinking. Psychol Sci 2005;16(7):572578.
    Direct Link:
  • 61
    Good C, Aronson J, Harder JA. Problems in the pipeline: stereotype threat and women's achievement in high-level math courses. J Appl Dev Psychol 2008;29(1):1728.
  • 62
    Hess T, Auman C, Colcombe S, Rahhal T. The impact of stereotype threat on age differences in memory performance. J Gerontol Psychol Sci 2003;58(1):311.
  • 63
    Mazerolle M, Regner I, Morisset P, Rigalleau F, Huguet P. Stereotype threat strengthens automatic recall and undermines controlled processes in older adults. Psychol Sci 2012;23:723727.
  • 64
    Cole JC, Michailidou K, Jerome L, Sumnall HR. The effects of stereotype threat on cognitive function among ecstasy users. J Psychopharmacol 2006;20:518525.
  • 65
    Schmader T, Johns M, Forbes C. An integrated process model of stereotype threat effects on performance. Psychol Rev 2008;115:336356.
  • 66
    Kane MJ, Engle RW. Working memory capacity and the control of attention: the contributions of goal neglect, response competition, and task set to Stroop interference. J Exp Psychol Gen 2003;132:4770.
  • 67
    Schmader T, Johns M. Converging evidence that stereotype threat reduces working memory capacity. J Pers Soc Psychol 2003;85(3):440452.
  • 68
    Schagen SB, Das E, Vermeulen I. Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients. Psycho-Oncology 2012;21(10):11321135.
  • 69
    Pinel EC. Stigma consciousness: the psychological legacy of social stereotypes. J Pers Soc Psychol 1999;76:114128.
  • 70
    Rydell B J, McConnel, AR, Beilock SL. Multiple social identities and stereotype threat: imbalance, accessibility, and working memory. J Pers Soc Psychol 2009;96:949966.
  • 71
    Brown RP, Pinel EC. Stigma on my mind: individual differences in the experience of stereotype threat. J Exp Soc Psychol 2003;39:626633.
  • 72
    Das E, Jacobs W, Monster S, Schagen SB. Priming cognitive problems following chemotherapy: the role of stigma consciousness. ICCTF Cognition Cancer Conference 2012; March 15–17: Paris, France.
  • 73
    Ståhl T, Van Laar C, Ellemers N. The role of prevention focus under stereotype threat: initial cognitive mobilization is followed by depletion. J Pers Soc Psychol 2012;102:12391251.
  • 74
    Mrazek MD, Chin JM, Schmader T, Hartson KA, Smallwood J, Schooler J. Mind wandering as a consequence of stereotype threat. J Exp Soc Psychol 2011;47:124348.
  • 75
    Jamieson JP, Harkins SG. Mere effort and stereotype threat performance effects. J Pers Soc Psychol 2007;93(4):544564.
  • 76
    Smith JL. Understanding the process of stereotype threat: a review of mediational variables and new performance goal directions. Educ Psychol Rev 2004;16(3):177206.
  • 77
    Inzlicht M, Kang SK. Stereotype threat spillover: how coping with threats to social identity affects aggression, eating, decision making, and attention. J of Per Soc Psychol 2010;99(3):467481.
  • 78
    Schmader T, Hall W, Croft A. Stereotype threat in intergroup relations. In J. Simpson & J. Dovidio (Eds.) APA Handbook of Personality and Social Psychology. (n.d). Washington, D.C., APA, in press.
  • 79
    Park C., Zlateva I, Blank TO. Self-Identity after cancer: “Survivor”, “Victim”, “Patient”, and “Person with cancer”. J Gen Internal Med 2009;24 (Supplement 2):S430S435.
  • 80
    Ferguson RJ, McDonald BC, Rocque MA, et al. Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial. Psycho-Oncology 2012;21(2):176186.
  • 81
    Johns M, Schmader S, Martens M. Knowing is half the battle: teaching stereotype threat as a means of improving women's math performance. Psychol Sci 2005;16(3):175179.
    Direct Link:
  • 82
    Ahles TA, Saykin AJ, Noll WW, Furstenberg CT, Guerin S, Cole B, Mott LA. The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psycho-Oncology 2003;12:612619.
  • 83
    Small BJ, Rawson KS, Walsh E, Jim HSL, Hughes TF, Iser L, Andrykowski MA, Jacobsen PB. Cathechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors. Cancer 2011;117:13691376.